ZURICH, Oct 4 (Reuters) - The Swiss blue-chip SMI was seen opening 0.3 percent higher at 8,188 points on Tuesday, according to premarket indications by bank Julius Baer .
The following are some of the main factors expected to affect Swiss stocks:
ABB said it was hanging on to its Power Grids business, rejecting calls from shareholders who have campaigned for the $11.6 billion unit to be separated from the Swiss engineering group.
Shares were seen opening up 1.6 percent in premarket indicators.
For more news, click
Roche said its lung cancer drug Alecensa (alectinib), developed by its Genentech unit, received a second breakthrough therapy designation (BTD) from the U.S. Food and Drug Administration (FDA) for its anaplastic lymphoma kinase (ALK) inhibitor.
For more news, click
Syngenta said it invested a combined total of $240 million in two plants in Brazil and Switzerland.
For more, click on
* Swiss Life named Roman Stein as CFO for Swiss Life Schweiz as of Jan. 1.
* Santhera announced the appointment of Kristina Timdahl as chief medical officer and head of development as of January 2017.
* Clariant said it will open a Global Competence Center Haircare in São Paulo, Brazil.
* Temenos confirmed Bank of Ireland Group had selected UniversalSuite, after announcing earlier on Monday that a major European bank had selected UniversalSuite.
* GAM said it completed the acquisition of Cantab Capital Partners LLP, which was first announced on June 29.
* Novavest said it has extended its property portfolio with the acquisition of two properties in Frauenfeld and in Zurich.
* HBM Healthcare Investments said its was launching a new share buy-back programme of up to 730,000 shares (10 percent of total shares issued) for the purpose of cancellation by way of a capital reduction. It also said net asset value per share increased increased by 5.3 percent during the second quarter of the current financial year to 139.42 Swiss francs as at 30 September 2016.
* Siegfried Holding announced an increase of 15 million Swiss francs to the subordinated public hybrid bond launched on Sept. 26, bringing the new total outstanding amount to 160 million francs.
* SGS said it acquired AXYS Analytical Services Ltd. (AXYS), Sidney, British Columbia, Canada, that is expected to generate 2016 revenues in excess of CAD 12 million.
* Dottikon ES and Bachem announce that they are extending their collaboration in the area of novel amino acids.
* DKSH said it has been appointed by The Procter & Gamble Company, Cincinnati/USA to sell and distribute P&G’s brands in Hong Kong.
Reporting by Zurich newsroom